Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 03, 2026
TickeronGET DAILY SIGNALS
Everus Construction Group (ECG) Delivers Record Q3 Revenue and Raises Full-Year Outlook

Everus Construction Group (ECG) Delivers Record Q3 Revenue and Raises Full-Year Outlook

Key Takeaways

  • Everus Construction Group (ECG) posted third-quarter 2026 revenue of $1.38 billion, a quarterly record and a 39.8% increase from the prior-year period.
  • GAAP diluted earnings per share (EPS) came in at $1.79, well above the consensus estimate of roughly $1.28.
  • For the first nine months of 2026, net income rose 59.8% to $234.1 million, or $4.57 per diluted share, versus $2.87 a year earlier.
  • Management raised its full-year 2026 guidance, now targeting revenue of $5.0 billion to $5.1 billion and adjusted EBITDA of $485 million to $495 million.
  • Demand remained strong across data centers, high-tech manufacturing, and power transmission and distribution projects.

Earnings Context and Why It Matters

Everus Construction Group (ECG) operates as a specialty contracting and construction-solutions provider through its Electrical & Mechanical and Transmission & Distribution segments. Throughout 2026 the company has benefited from strong demand tied to data-center infrastructure, high-tech manufacturing facilities, and power transmission work, while integrating recent acquisitions including SE&M and Epsilon Industries. Before this earnings release the stock had retreated from its peaks despite earlier guidance increases, so the third-quarter results served as an important test of whether the elevated backlog would support sustained earnings growth. From what I see, this quarter provided a useful check on margins, backlog conversion, and the reliability of the updated outlook.

Reported Results

Everus reported third-quarter 2026 revenue of $1.38 billion, up 39.8% from $986.8 million in the same period a year earlier and ahead of the consensus estimate of roughly $1.19 billion. GAAP diluted EPS reached $1.79, exceeding the consensus estimate of about $1.28 and improving from $1.11 in the prior-year quarter. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Net income for the quarter was approximately $91.9 million, compared with about $57.0 million a year ago. For the first nine months of 2026, revenue reached $3.65 billion, net income climbed 59.8% to $234.1 million, and diluted EPS rose to $4.57 from $2.87. Adjusted EBITDA increased 52.2% to $357.7 million for the nine-month period, with the EBITDA margin expanding to 9.8% from 8.6%.

Given the strong first three quarters and completed acquisitions, management raised its full-year 2026 guidance. The company now expects revenue of $5.0 billion to $5.1 billion, up from the prior range of $4.5 billion to $4.7 billion, and adjusted EBITDA of $485 million to $495 million, up from $410 million to $425 million.

Market Reaction and Investor Sentiment

Sentiment ahead of the report had grown cautious. Everus shares had declined roughly 35% from their post-guidance highs, even as management issued consecutive outlook increases, leaving the stock near its post-report low and below its 200-day moving average. The combination of a quarterly revenue record, an EPS beat, and a second guidance raise helped improve the tone, with shares trading higher in the session after the release. Investors focused most on the durability of demand signals and the company’s confidence in lifting its full-year targets.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors will watch whether Everus can maintain momentum into the fourth quarter and convert its elevated backlog into revenue and profit. The company had previously indicated that back-half margins would moderate from the second quarter’s elevated levels, so any indication that margins hold above plan would support confidence in pricing power and project execution.

Backlog composition will stay in focus. Management has noted that recent growth has not been driven solely by data centers, and continued diversification across commercial, industrial, and semiconductor work would help address concentration concerns. Progress on the Epsilon Industries and SE&M integrations will also matter, as will any updates on labor, material, and tariff-related cost pressures that could affect margins on fixed-price contracts.

Finally, cash-flow trends deserve attention. Strong first-half free cash flow benefited from working-capital timing that management expects to reverse, so a softer third-quarter figure on its own may not signal a problem. Overall, the key question remains whether Everus can show that its record demand leads to durable, broad-based earnings power rather than a temporary data-center-driven surge.

Using Tickeron’s AI Tools for Deeper Analysis

In my own research process I often turn to Tickeron’s AI-powered tools to cross-check patterns and compare opportunities across the sector. One resource I find particularly helpful is the AI Screener, which lets users apply filters for technical patterns, fundamentals, and performance metrics to surface comparable ideas more efficiently. It has become a regular part of how I evaluate names like Everus Construction Group (ECG) alongside peers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ECG

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Aroon Indicator for ECG shows an upward move is likely

ECG's Aroon Indicator triggered a bullish signal on October 14, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 131 similar instances where the Aroon Indicator showed a similar pattern. In 118 of the 131 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ECG's RSI Oscillator exited the oversold zone, 3 of 5 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 14 of 17 cases where ECG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

Following a +6.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECG advanced for three days, in 104 of 121 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECG as a result. In 26 of 38 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.

The Moving Average Convergence Divergence Histogram (MACD) for ECG turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 20 similar instances when the indicator turned negative. In 13 of the 20 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.

ECG moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ECG crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

ECG broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.802) is normal, around the industry mean (15.267). P/E Ratio (20.681) is within average values for comparable stocks, (166.907). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.198) among similar stocks. P/S Ratio (1.335) is also within normal values, averaging (2.856).

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. ECG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.

Notable companies

The most notable companies in this group are MasTec (NYSE:MTZ).

Industry description

Engineering & Construction includes companies that engage in non-residential construction and contract services, including ventilation, heating and air conditioning (HVAC) services. The level/value of construction & engineering activity is one of the potentially relevant indicators of the health of businesses, and hence of the overall economy. Some of the large-cap U.S. companies in this industry include Jacobs Engineering Group Inc,, AECOM and Quanta Services, Inc.

Market Cap

The average market capitalization across the Engineering & Construction Industry is 7.39B. The market cap for tickers in the group ranges from 69 to 2.15T. WKAPF holds the highest valuation in this group at 2.15T. The lowest valued company is WLGSF at 69.

High and low price notable news

The average weekly price growth across all stocks in the Engineering & Construction Industry was 5%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -26%. ONEG experienced the highest price growth at 96%, while OFAL experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Engineering & Construction Industry was 29%. For the same stocks of the Industry, the average monthly volume growth was 31% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 58
Price Growth Rating: 65
SMR Rating: 71
Profit Risk Rating: 76
Seasonality Score: -14 (-100 ... +100)
View a ticker or compare two or three
ECG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry EngineeringConstruction

Industry
N/A
Address
1730 Burnt Boat Drive
Phone
+1 701 221-6400
Employees
9400
Web
https://everus.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of approximately $8.5 billion, a roughly 5% increase from $8.1 billion in Q1 2025. Consensus adjusted earnings per share (EPS) forecast stands at $4.74, reflecting a potential decline from prior-year levels amid pricing pressures.
Analysts expect Q1 2026 adjusted EPS of around $1.61, down from prior year levels due to softer commodity prices. Consensus revenue forecast stands at approximately $14.5 billion, reflecting a year-over-year decline.